Profiel
Rob Henderson worked as the Director of Product Management at Corixa Corp.
He then served as the Chief Scientific Officer at Viridian Therapeutics, Inc. from 2021 to 2024.
Dr. Henderson obtained his undergraduate degree from the University of Virginia.
Eerdere bekende functies van Rob Henderson
Bedrijven | Functie | Einde |
---|---|---|
VIRIDIAN THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2024 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Corporate Officer/Principal | - |
Opleiding van Rob Henderson
University of Virginia | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
VIRIDIAN THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |